Member Info for Arsenal786

Agreed - the webinar has kept me on board - lots of positives to be had, and were at the start of an exciting post-covid period.

Hoping for some news in the webinar today...

If not, then opportunities elsewhere in the short term.

"The big money is not in the buying or selling, but in the waiting"

Haha of course, In that case every man should have this in their man bag.

Market potential is huge either way.

On a few fronts:

A) the number of sells I’m seeing
B) the price target of our in house broker seems to be ridiculous
C) the number of options given at the 15p mark.
D) completely lost its momentum

Still holding but only just.

First line of defence meaning you go to a doctor with the ED issue, the first things they’ll likely prescribe/ ask you to try is the gel, as there are virtually no medical side effects.

Just awaiting regulatory approval, and a commercial partner - both big ticket items in their own right but results from Phase 3 testing and pre-submission discussions with the regulatory boards show that FUM definitely have a product that is approvable, marketable as there is a genuine need as a first line of defence in erectile dysfunction arena so in which Liberum think it will take a 15% market share (the company think 50% is achievable)..

So either £300 mill of revenue/ £1bill.

NCYT type share growth all over again. You’ll look back at this in 6 months time either with lots of regret that you sold too early or so much happiness from 10+++ bagging.

Not surprised by the SP movement today and for me it’s definitely a hold for the next 6-9 months. There’s so many good things going for it and a steady positive news stream to come over the course of 2020. 20p will look cheap in a few months time.

Rating given by Liberum - a low target of 55p - 85p depending on patent approval....Giving a Mcap range of c£137m - 210m...

Liberum: FUM have a £300m revenue generating product based on low estimates (FUM believe they have a £1bn generating product) - so Liberum have been super conservative here.

Quick back of a fag packet workings - Assuming £300m Revenue generates £30m EBITDA x (a low multiple for the industry) 12 = £360m valuation

or 146p.

Stong buy if all falls into place.

Good to read the strong interest for marketing rights for Med3000 in the Financial statements. Here we have a potentially £1bn in revenue product on our hands awaiting regulatory approval.

Futura are well positioned to deliver further positive news through 2020, and I can’t wait.

Just thinking of the financial prospects of an approved Med3000 will bring to the company and shareholders is super exciting.

And significantly undervalued: This company has fantastic revenue growth from large global business, its growing profits and cash.

Strong buy IMHO, and I don’t usually give out an opinion on buy/sell

All mentioned...and in discussions with in the investor catch up!!!

Excellent news, and an absolute game changer if they get them on board!!!

@YstoneAdvisory - FY rev +274% and +129% in Q1. V strong Cash pos. China improving strongly. Advanced partnership discussions with multiple tier 1's in US (Disney/Netflix?), P&G's now running campaigns.___New partnership with Channel 4,Tier 1 partner (Netflix/Apple/Amazon/Disney) in advance stages.Enough cash to see them through to 2021, where they expect they’ll increase revenues by a more than the current multiples.Looking forward to the presentation later.

If growth continues as it has done previously, then this share will become big-time very soon.

The update from last week included some big names in China: Huawei, WeChat etc... I’m expecting more of the same in the coming months... and as you said they’ll have enough cash in the bank, alongside the guaranteed cash coming in from Tencent.

Anythign significant in Q1 2021 will get a mention in the post-balance sheet events. Fingers crossed!

Will be interesting to see if they disclose any new deals, and maybe some more detail of the discussions they have been having in the US (its in one of the video presentations they have) ... If these guys can bag Netflix/Disney/YouTube...then oh my days!!

Interesting to see James Barder move his holding to an ISA.

Im sure he will get a nice healthy tax free lump of cash coming his way.

Can potentially see Pfizer coming in for an exclusive partnership and using the Viagra brand to market a new revolutionary gel!!

Watch this space.

Price is looking sexy right now

5.5p target :)